Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination?
Fiche publication
Date publication
novembre 2021
Journal
Vaccine
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERCEANU Ana, Pr DECONINCK Eric
Tous les auteurs :
Pierron A, Bozon F, Berceanu A, Fontan J, Brion A, Deconinck E, Chirouze C, Brunel AS
Lien Pubmed
Résumé
Immunocompromised patients are at high-risk for severe influenza and invasive pneumococcal diseases (IPD). Despite the French Public Health Council (FPHC) and the 7th European Conference on Infections in Leukaemia (ECIL7) recommendations, vaccination coverage remains insufficient. This study aimed to estimate the coverage and determinants of influenza, pneumococcal and diphtheria-tetanus-poliomyelitis (dTP) vaccinations in hematological patients underlying chemotherapy.
Mots clés
Chemotherapy, General practitioners, Immunocompromised host, Influenza, Pneumococcal, Vaccination
Référence
Vaccine. 2021 Nov 2;: